Non Small Cell Lung Cancer (NSCLC)

SEP 9, 2026 · INTERVENTIONAL STUDY

Wireless Wearable Home Prehabilitation for Older Adults With NSCLC

ClinicalTrials.gov

This is a clinical trial registration with no reported results; the study is actively recruiting and outcome data are not yet available for analysis.

SEP 8, 2026 · PHASE 2 TRIAL

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

ClinicalTrials.gov

Phase 2 interventional trial with planned safety and efficacy endpoints in EGFR-mutant NSCLC; no results reported in this registry record.

SEP 8, 2026 · PHASE 3 TRIAL

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ClinicalTrials.gov

This is a registered Phase 3 trial currently recruiting with no results posted; it describes a planned comparison but carries no outcome data.

AUG 7, 2026 · PHASE 1/2 TRIAL

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov

This is a Phase 1/2 trial registration with no results posted; the study is actively recruiting and has not yet reported efficacy or safety outcomes.